iNtRON Biotechnology Inc - Asset Resilience Ratio

Latest as of September 2025: 10.90%

iNtRON Biotechnology Inc (048530) has an Asset Resilience Ratio of 10.90% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

₩8.58 Billion

≈ $5.81 Million USD Cash + Short-term Investments

Total Assets

₩78.70 Billion

≈ $53.34 Million USD All company assets

Resilience Assessment

Moderate

Financial Resilience Level

Asset Resilience Ratio Trend (2012–2024)

This chart shows how iNtRON Biotechnology Inc's Asset Resilience Ratio has changed over time. Check asset allocation strategy of iNtRON Biotechnology Inc to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down iNtRON Biotechnology Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 048530 market cap.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	₩0.00	0%
Short-term Investments	₩8.58 Billion	10.9%
Total Liquid Assets	₩8.58 Billion	10.90%

Asset Resilience Insights

Moderate Liquidity: iNtRON Biotechnology Inc has 10.90% of assets in liquid form.
While adequate for normal operations, this level may limit flexibility during economic stress.
The company has significant short-term investments, indicating active treasury management.

iNtRON Biotechnology Inc Industry Peers by Asset Resilience Ratio

Compare iNtRON Biotechnology Inc's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Tubize-Fin BR:TUB	Biotechnology	0.05%
Verona Pharma plc F:I9SA	Biotechnology	0.00%
Xiamen Amoytop Biotech Co Ltd SHG:688278	Biotechnology	4.69%
Syndax Pharmaceuticals Inc NASDAQ:SNDX	Biotechnology	46.79%
Neuren Pharmaceuticals Ltd AU:NEU	Biotechnology	90.43%
Vor Biopharma Inc NASDAQ:VOR	Biotechnology	63.47%
Chengdu Kanghua Biological Products SHE:300841	Biotechnology	1.19%
Jiangsu Aidea Pharmaceutical Co Ltd SHG:688488	Biotechnology	4.35%

Annual Asset Resilience Ratio for iNtRON Biotechnology Inc (2012–2024)

The table below shows the annual Asset Resilience Ratio data for iNtRON Biotechnology Inc.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	17.85%	₩15.42 Billion ≈ $10.45 Million	₩86.37 Billion ≈ $58.53 Million	-40.14pp
2023-12-31	57.99%	₩57.18 Billion ≈ $38.75 Million	₩98.61 Billion ≈ $66.83 Million	+24.40pp
2022-12-31	33.59%	₩47.35 Billion ≈ $32.09 Million	₩140.96 Billion ≈ $95.53 Million	-20.85pp
2021-12-31	54.44%	₩83.49 Billion ≈ $56.58 Million	₩153.37 Billion ≈ $103.93 Million	-11.37pp
2020-12-31	65.81%	₩66.16 Billion ≈ $44.84 Million	₩100.54 Billion ≈ $68.13 Million	+2.50pp
2019-12-31	63.32%	₩56.37 Billion ≈ $38.20 Million	₩89.03 Billion ≈ $60.34 Million	+24.70pp
2018-12-31	38.62%	₩21.16 Billion ≈ $14.34 Million	₩54.80 Billion ≈ $37.13 Million	-3.16pp
2017-12-31	41.77%	₩19.06 Billion ≈ $12.92 Million	₩45.63 Billion ≈ $30.92 Million	+2.51pp
2016-12-31	39.26%	₩23.40 Billion ≈ $15.86 Million	₩59.61 Billion ≈ $40.39 Million	+29.03pp
2015-12-31	10.23%	₩4.13 Billion ≈ $2.80 Million	₩40.37 Billion ≈ $27.36 Million	-3.92pp
2012-12-31	14.15%	₩2.78 Billion ≈ $1.88 Million	₩19.64 Billion ≈ $13.31 Million	--

pp = percentage points

About iNtRON Biotechnology Inc

KQ:048530 Korea Biotechnology

Market Cap

$55.81 Million

₩82.35 Billion KRW

Market Cap Rank

#21432 Global

#1228 in Korea

Share Price

₩2605.00

Change (1 day)

+6.98%

52-Week Range

₩2330.00 - ₩6650.00

All Time High

₩46250.00